Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

15 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Patterns of response and acquired resistance to the programmed death-1 inhibitor pembrolizumab in Stage III metastatic cutaneous squamous cell carcinoma.
Zalaudek I, Corneli P, Vernoni S, Fedele D, Papa G, Conforti C, Retrosi C, Vezzoni R, Fagotti S, Longone M, Farinazzo E, di Meo N, Pizzichetta MA. Zalaudek I, et al. Among authors: farinazzo e. Dermatol Ther. 2019 Nov;32(6):e13107. doi: 10.1111/dth.13107. Epub 2019 Oct 21. Dermatol Ther. 2019. PMID: 31595596 No abstract available.
Current therapies for actinic keratosis.
Dianzani C, Conforti C, Giuffrida R, Corneli P, di Meo N, Farinazzo E, Moret A, Magaton Rizzi G, Zalaudek I. Dianzani C, et al. Among authors: farinazzo e. Int J Dermatol. 2020 Jun;59(6):677-684. doi: 10.1111/ijd.14767. Epub 2020 Feb 3. Int J Dermatol. 2020. PMID: 32012240 Free article. Review.
Pattern of response of unresectable and metastatic cutaneous squamous cell carcinoma to programmed death-1 inhibitors: A review of the literature.
Corneli P, Conforti C, Retrosi C, Vezzoni R, di Meo N, Piccolo V, Farinazzo E, Russo T, Magaton Rizzi G, Giuffrida R, Zalaudek I. Corneli P, et al. Among authors: farinazzo e. Dermatol Ther. 2020 Mar;33(2):e13250. doi: 10.1111/dth.13250. Epub 2020 Feb 20. Dermatol Ther. 2020. PMID: 32022968 Free article. Review.
Secukinumab-induced subacute cutaneous lupus erythematosus.
Conforti C, Retrosi C, Giuffrida R, Vezzoni R, Currado D, Navarini L, Farinazzo E, Dell'Aquila C, Nan K, Di Meo N, Zalaudek I. Conforti C, et al. Among authors: farinazzo e. Dermatol Ther. 2020 May;33(3):e13417. doi: 10.1111/dth.13417. Epub 2020 May 3. Dermatol Ther. 2020. PMID: 32291870 Free article. No abstract available.
Inverse psoriasis in patient treated with atezolizumab.
Corneli P, di Meo N, Fagotti S, Conforti C, Farinazzo E, Zacchi A, Retrosi C, Vezzoni R, Pizzichetta MA, Zalaudek I. Corneli P, et al. Among authors: farinazzo e. Int J Dermatol. 2020 Sep;59(9):e331-e332. doi: 10.1111/ijd.14876. Epub 2020 Apr 28. Int J Dermatol. 2020. PMID: 32346858 Free article. No abstract available.
Dupilumab as promising treatment for prurigo nodularis: current evidences.
Toffoli L, Farinazzo E, Zelin E, Agozzino M, Dianzani C, Di Meo N, Nan K, Zalaudek I, Conforti C. Toffoli L, et al. Among authors: farinazzo e. J Dermatolog Treat. 2022 May;33(3):1306-1311. doi: 10.1080/09546634.2021.1886232. Epub 2021 Feb 15. J Dermatolog Treat. 2022. PMID: 33588666 Free article. Review.
Oral ulcers as presenting symptom of B-cell acute lymphoblastic leukemia.
Farinazzo E, Conforti C, Corneli P, Romano A, Moret A, Di Meo N, Schmid-Zalaudek K, Zalaudek I. Farinazzo E, et al. J Dtsch Dermatol Ges. 2021 May;19(5):755-757. doi: 10.1111/ddg.14424. Epub 2021 Feb 26. J Dtsch Dermatol Ges. 2021. PMID: 33634568 No abstract available.
Cutaneous adverse reactions after m-RNA COVID-19 vaccine: early reports from Northeast Italy.
Farinazzo E, Ponis G, Zelin E, Errichetti E, Stinco G, Pinzani C, Gambelli A, De Manzini N, Toffoli L, Moret A, Agozzino M, Conforti C, Di Meo N, Schincariol P, Zalaudek I. Farinazzo E, et al. J Eur Acad Dermatol Venereol. 2021 Sep;35(9):e548-e551. doi: 10.1111/jdv.17343. Epub 2021 Jun 7. J Eur Acad Dermatol Venereol. 2021. PMID: 34021625 Free PMC article. No abstract available.
15 results